4//SEC Filing
Anders Jack 4
Accession 0001610717-25-000346
CIK 0001628171other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:34 PM ET
Size
4.7 KB
Accession
0001610717-25-000346
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-09-16$45.82/sh−2,320$106,314→ 110,994 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 48,275 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001800668
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:34 PM ET
- Size
- 4.7 KB